
In recent years, with the maturity of automation technology, local pharmaceutical manufacturers have gradually transformed and started to deploy fully automated production lines. With this trend, the drug bottle detector has entered many pharmaceutical and health product manufacturers, providing a good opportunity for pharmaceutical industry enterprises to reduce the rate of defective products, improve the drug quality and the overall automation level of the production line.
Many pharmaceutical and health care product manufacturers use automated methods for early production, post packaging, and post packaging inspection processes to reduce the low efficiency and huge labor and management costs caused by manual inspection. In order to meet the quality requirements, many pharmaceutical factories combine machine vision systems and automated machines (production line machines) to eliminate the products with defects such as black spots, dirt, missing flash, deformation and so on from the drug bottles through high-speed photography data, so as to achieve high-quality and cost-effective production line processes.
In fact, with the help of machine vision system, the overall detection efficiency and accuracy of drug bottles in the detection link have been greatly improved compared with the previous human efficiency. The industrial camera in the detector system can capture the image of each drug bottle passing through the high-speed production line, and then analyze it by the back-end image software to screen the good/bad products. At the same time, it can also record the image data, so that the subsequent sequence can quickly and accurately query, trace and retrieve the items. Various automatic auxiliary machines can also be connected at the front and rear ends of the detection to comprehensively improve the automation level of the production line.
The medicine bottle detector system can greatly improve the quality of medicine bottles produced outside, reduce defects, improve customer satisfaction, significantly reduce labor costs, reduce the cost of pharmaceutical enterprises, and significantly improve production efficiency, which can shorten the production cycle of medicine bottles, improve Party A's satisfaction, and obtain more production orders.
